Ocular Therapeutix (OCUL)
NASDAQ:OCUL
Holding OCUL?
Track your performance easily

Ocular Therapeutix (OCUL) Technical Analysis

1,377 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
5Neutral
4Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Ocular Therapeutix’s (OCUL) Moving Averages Convergence Divergence (MACD) indicator is 0.14, suggesting Ocular Therapeutix is a Buy.
Ocular Therapeutix’s (OCUL) 20-Day exponential moving average is 8.60, while Ocular Therapeutix’s (OCUL) share price is $9.05, making it a Buy.
Ocular Therapeutix’s (OCUL) 50-Day exponential moving average is 8.17, while Ocular Therapeutix’s (OCUL) share price is $9.05, making it a Buy.

Ocular Therapeutix (OCUL) Pivot Points

Sep 19, 2024, 06:18 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.30
8.47
8.70
8.87
9.10
9.27
9.50
Fibonacci
8.47
8.62
8.72
8.87
9.02
9.12
9.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ocular Therapeutix (OCUL) Moving Averages

Sep 19, 2024, 06:18 PM
Period
Simple
Exponential
MA5
8.77Sell
8.76Sell
MA10
8.58Buy
8.69Buy
MA20
8.74Buy
8.60Buy
MA50
8.30Buy
8.17Buy
MA100
7.05Buy
7.57Buy
MA200
6.75Buy
6.52Buy
Ocular Therapeutix’s (OCUL) 10-Day exponential moving average is 8.69, while Ocular Therapeutix’s (OCUL) share price is $9.05, making it a Buy.
Ocular Therapeutix’s (OCUL) 100-Day exponential moving average is 7.57, while Ocular Therapeutix’s (OCUL) share price is $9.05, making it a Buy.
Ocular Therapeutix’s (OCUL) stock price is $9.05 and Ocular Therapeutix’s (OCUL) 50-day simple moving average is 8.30, creating a Buy signal.
Ocular Therapeutix’s (OCUL) stock price is $9.05 and Ocular Therapeutix’s (OCUL) 100-day simple moving average is 7.05, creating a Buy signal.
Ocular Therapeutix’s (OCUL) stock price is $9.05 and Ocular Therapeutix’s (OCUL) 200-day simple moving average is 6.75, creating a Buy signal.

Ocular Therapeutix (OCUL) Technical Indicators

Sep 19, 2024, 06:18 PM
Name
Value
Implied Action
RSI (14)
55.08
Neutral
STOCH (9,6)
82.72
Sell
STOCHRSI (14)
76.51
Neutral
MACD (12,26)
0.14
Buy
ADX (14)
22.32
Neutral
Williams %R
-31.75
Buy
CCI (14)
30.88
Neutral
ATR (14)
0.42
-
Ultimate Oscillator
58.53
Neutral
ROC
-3.10
Sell
Ocular Therapeutix’s (OCUL) Relative Strength Index (RSI) is 55.08, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Trend Strength Indicator (ADX) is 22.32, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Commodity Channel Index (CCI) is 30.88, creating a Neutral signal.
Ocular Therapeutix’s (OCUL) Price Rate of Change (ROC) is -3.10, creating a Sell signal.

FAQ

Is OCUL a Buy, Hold, or Sell?
Based on OCUL’s technical indicators, OCUL is a Buy.
    What is OCUL’s RSI (14)?
    OCUL’s RSI (14) is 55.08, which suggests OCUL is a Neutral.
      What is OCUL’s MACD?
      OCUL’s MACD is 0.14, which suggests OCUL is a Buy.
        What is OCUL’s 5-day moving average?
        OCUL’s 5-day moving average is 8.77, which suggests OCUL is a Sell.
          What is OCUL’s 20-day moving average?
          OCUL 20-day moving average is 8.74, which suggests OCUL is a Buy.
            What is OCUL’s 50-day moving average?
            OCUL’s 50-day moving average is 8.30, which suggests OCUL is a Buy.
              What is OCUL’s 200-day moving average?
              OCUL’s 200-day moving average is 6.75, which suggests OCUL is a Buy.
                What is OCUL’s Williams % R (14)?
                OCUL’s Williams % R (14) is -31.75, which suggests OCUL is a Buy.
                  What is OCUL’s CCI (14)?
                  OCUL’s CCI (14) is 30.88, which suggests OCUL is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis